<DOC>
	<DOCNO>NCT01402947</DOCNO>
	<brief_summary>This drug interaction study evaluate pharmacokinetic profile Ciprofloxacin XR administer alone &amp; combination MMX Mesalazine/mesalamine .</brief_summary>
	<brief_title>Ciprofloxacin XR Drug Interaction Study With MMXÂ® Mesalazine/Mesalamine</brief_title>
	<detailed_description />
	<mesh_term>Mesalamine</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Inclusion Criteria 1 . Age 1855 year inclusive time consent . The date signing informed consent define begin Screening Period . 2 . Subject willing comply applicable contraceptive requirement protocol : Male , Nonpregnant , nonlactating female Females must least 90 day postpartum nulliparous . Exclusion Criteria 1 . A history current recurrent disease could affect colon . This include gastrointestinal disease , peptic ulceration , gastrointestinal bleeding , celiac disease , lactose intolerance , ulcerative colitis , Crohn 's disease , Irritable Bowel Syndrome . Subjects history chronic constipation , physician diagnose treat , also exclude study ( frequency bowel movement &gt; 48 hour sample ) . 2 . A history current relevant serious , severe , unstable ( acute progressive ) physical psychiatric illness . 3 . A history gastrointestinal surgery perform within past 12 month prior first dose investigational product , exception appendectomy . 4 . A history current clinically relevant moderate severe renal hepatic impairment . 5 . A history asthma bronchospasm associate use 5ASA nonsteroidal antiinflammatory drug . 6 . Known suspected intolerance hypersensitivity investigational product ciprofloxacin XR , closely related compound , state ingredient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>